Dmitry Balyasny’s Molina Healthcare MOH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $378K | Buy |
+1,655
| New | +$300K | ﹤0.01% | 2639 |
|
|
2026
Q1 | – | Sell |
-50,392
| Closed | -$8.75M | – | 3276 |
|
|
2025
Q4 | $8.75M | Sell |
50,392
-11,510
| -19% | -$1.89M | 0.01% | 1092 |
|
|
2025
Q3 | $11.8M | Buy |
+61,902
| New | +$11.4M | 0.02% | 968 |
|
|
2025
Q2 | – | Sell |
-1,155
| Closed | -$380K | – | 3152 |
|
|
2025
Q1 | $380K | Sell |
1,155
-211
| -15% | -$63.7K | ﹤0.01% | 2368 |
|
|
2024
Q4 | $398K | Sell |
1,366
-30,500
| -96% | -$9.42M | ﹤0.01% | 2276 |
|
|
2024
Q3 | $11M | Buy |
31,866
+30,883
| +3,142% | +$10.2M | 0.02% | 899 |
|
|
2024
Q2 | $292K | Sell |
983
-1,133
| -54% | -$385K | ﹤0.01% | 2234 |
|
|
2024
Q1 | $869K | Buy |
2,116
+625
| +42% | +$242K | ﹤0.01% | 1854 |
|
|
2023
Q4 | $539K | Buy |
+1,491
| New | +$526K | ﹤0.01% | 1923 |
|
|
2023
Q2 | – | Sell |
-1,669
| Closed | -$446K | – | 2602 |
|
|
2023
Q1 | $446K | Buy |
1,669
+868
| +108% | +$249K | ﹤0.01% | 1981 |
|
|
2022
Q4 | $265K | Sell |
801
-10,683
| -93% | -$3.63M | ﹤0.01% | 2044 |
|
|
2022
Q3 | $3.79M | Buy |
+11,484
| New | +$3.7M | 0.01% | 1157 |
|
|
2022
Q2 | – | Sell |
-5,858
| Closed | -$1.95M | – | 3010 |
|
|
2022
Q1 | $1.95M | Buy |
+5,858
| New | +$1.8M | 0.01% | 1385 |
|
|
2021
Q3 | – | Sell |
-26,634
| Closed | -$6.74M | – | 2252 |
|
|
2021
Q2 | $6.74M | Buy |
26,634
+15,319
| +135% | +$3.85M | 0.03% | 629 |
|
|
2021
Q1 | $2.65M | Buy |
+11,315
| New | +$2.52M | 0.01% | 933 |
|
|
2019
Q4 | – | Sell |
-5,023
| Closed | -$551K | – | 1362 |
|
|
2019
Q3 | $551K | Sell |
5,023
-4,385
| -47% | -$568K | ﹤0.01% | 926 |
|
|
2019
Q2 | $1.35M | Buy |
9,408
+4,300
| +84% | +$589K | 0.01% | 997 |
|
|
2019
Q1 | $725K | Buy |
+5,108
| New | +$691K | ﹤0.01% | 1100 |
|
|
2018
Q4 | – | Sell |
-13,538
| Closed | -$2.01M | – | 1612 |
|
|
2018
Q3 | $2.01M | Sell |
13,538
-27,908
| -67% | -$3.56M | 0.01% | 974 |
|
|
2018
Q2 | $4.06M | Buy |
41,446
+31,456
| +315% | +$2.74M | 0.02% | 725 |
|
|
2018
Q1 | $811K | Sell |
9,990
-44,140
| -82% | -$3.55M | ﹤0.01% | 1299 |
|
|
2017
Q4 | $4.15M | Sell |
54,130
-36,368
| -40% | -$2.63M | 0.01% | 918 |
|
|
2017
Q3 | $6.22M | Buy |
90,498
+80,603
| +815% | +$5.25M | 0.02% | 644 |
|
|
2017
Q2 | $685K | Sell |
9,895
-1,239,004
| -99% | -$76M | ﹤0.01% | 1186 |
|
|
2017
Q1 | $57M | Buy |
1,248,899
+1,236,761
| +10,189% | +$64.7M | 0.27% | 86 |
|
|
2016
Q4 | $659K | Sell |
12,138
-788,693
| -98% | -$43.1M | ﹤0.01% | 1107 |
|
|
2016
Q3 | $46.7M | Buy |
800,831
+419,057
| +110% | +$23.1M | 0.27% | 122 |
|
|
2016
Q2 | $19.1M | Buy |
+381,774
| New | +$20.4M | 0.12% | 219 |
|
|
2015
Q3 | – | Sell |
-10,360
| Closed | -$728K | – | 1295 |
|
|
2015
Q2 | $728K | Buy |
10,360
+2,290
| +28% | +$153K | ﹤0.01% | 825 |
|
|
2015
Q1 | $543K | Buy |
+8,070
| New | +$466K | ﹤0.01% | 712 |
|
Other funds holding MOH
LIM
Dmitry Balyasny's MOH Position: Q2 2026 in Review
Dmitry Balyasny opened a new position in Molina Healthcare (MOH) in Q2 2026: 1,655 shares worth $378K. The stake represents ﹤0.01% of the portfolio and ranks #2639 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in MOH as recently as Q4 2025.
Dmitry Balyasny first reported a position in MOH in Q1 2015 and has held it in 30 quarters since. The position peaked at $57M in Q1 2017. 597 funds tracked by Wall St. Rank hold MOH as of Q2 2026.
- Dmitry Balyasny held 1,655 shares of Molina Healthcare worth $378K as of Q2 2026.
- Molina Healthcare was a new Dmitry Balyasny position in Q2 2026.
- Molina Healthcare made up ﹤0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #2639 holding.
- Dmitry Balyasny first reported a position in Molina Healthcare in Q1 2015 and has held it in 30 quarters since.
- Dmitry Balyasny's Molina Healthcare position peaked at $57M in Q1 2017.
- 597 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.